Showing results (71-80 of 265) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factorsA Gennari, B Salvadori, S Donati, et al.Journal of the Neurological Sciences|February 7, 1998
Chronic administration of suramin induces neurotoxicity in ratsA Di Paolo, R Danesi, F Innocenti, et al.Cancer|August 3, 1999
Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinomaA Falcone, A Antonuzzo, R Danesi, et al.British Journal of Cancer|November 1, 1993
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membraneR Danesi, S Del Bianchi, P Soldani, et al.Oncology|July 28, 2001
5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancerA Falcone, G Allegrini, G Masi, et al.Chemotherapy|January 1, 1990
Roxithromycin penetration into gingiva and alveolar bone of odontoiatric patientsM Del Tacca, R Danesi, N Bernardini, et al.Oncology|November 5, 1999
Infusions of fluorouracil and leucovorin: effects of the timing and semi-intermittency of drug deliveryA Falcone, G Allegrini, A Antonuzzo, et al.International Journal of Radiation Oncology, Biology, Physics|February 1, 1997
Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatmentL Fatigante, F Ducci, F Cartei, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexateF Innocenti, R Danesi, A Di Paolo, et al.American Journal of Clinical Oncology|August 1, 1990
Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancerP Macchiarini, R Danesi, R Mariotti, et al.Pageof 27